Microbix & Seegene Mexico Collaborate to Improve Test Accuracy

Executive Summary

• Microbix Biosystems and Seegene Mexico announce that Microbix’s third‑party quality assessment products (QAPs®) will be used to support the clinical deployment of Seegene’s Allplex™ and Anyplex™ HPV multiplex assays in Mexico.
• The collaboration aims to accelerate training, validation, and ongoing quality management for high‑risk human papilloma virus (HPV) detection across Mexican clinical laboratories.
• Both companies highlight the public‑health impact of expanding access to reliable HPV screening, with Microbix indicating plans to extend QAP support to additional Seegene assays beyond HPV.

Key Details

• Partnership Scope: Microbix’s external QAP products will be employed for Seegene Mexico’s Allplex and Anyplex HPV 28 Detection assays (detecting 19 high‑risk and 9 low‑risk HPV genotypes).
• Quality Management Benefits: Use of QAPs will facilitate rapid site training, validation, and continuous compliance with international quality standards for molecular diagnostics.
• Strategic Intent: Microbix intends to broaden support to Seegene’s respiratory, sexually‑transmitted, and other infectious disease assays in the future.
• Quotes:
• David Choi, CEO, Seegene Mexico: “Expanding access to Seegene’s Allplex and Anyplex HPV tests across Mexico will substantially improve public‑health efforts for cervical cancer surveillance… We’re pleased to collaborate with Microbix…”
• Phil Casselli, SVP Business Development, Microbix: “We’re delighted to be helping Seegene Mexico with the launch and adoption of the Anyplex and Allplex platforms… Microbix also intends to support Seegene assays for respiratory, sexually‑transmitted, and other infectious diseases.”
• Company Backgrounds:
• Seegene Mexico – national affiliate of South Korean diagnostics leader Seegene Inc., focused on multiplex PCR molecular tests.
• Microbix Biosystems – Canadian life‑sciences manufacturer with C$ 25.4 M revenue (FY2024), ISO‑9001/13485 accredited, FDA‑registered, and supplier of QAPs to >30 countries.

Notable Quotes

• “We believe that expanding access to Seegene’s Allplex and Anyplex HPV tests across Mexico will substantially improve public‑health efforts for cervical cancer surveillance.” – David Choi, CEO, Seegene Mexico
• “We’re delighted to be helping Seegene Mexico with the launch and adoption of the Anyplex and Allplex platforms… Microbix also intends to support Seegene assays for respiratory, sexually‑transmitted, and other infectious diseases.” – Phil Casselli, SVP Business Development, Microbix

Materiality Assessment: Material – Positive (the announcement introduces a new commercial partnership that could materially enhance revenue streams and market presence for both companies).